MYCN and neoplasm: Radiation and treatment with immunocytokine hu14.18-IL2, a fusion protein linking hu14.18 anti-GD2 mAb and IL2, produced significant anti-tumor response in NXS2 mice, but not in N-MYC driven 9464D-GD2 mice, compared to monotherapy.